Cinctive Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.93M | Sell |
41,974
-46,472
| -53% | -$3.25M | 0.16% | 166 |
|
|
2025
Q1 | $6.5M | Buy |
88,446
+3,793
| +4% | +$279K | 0.5% | 60 |
|
|
2024
Q4 | $5.55M | Buy |
84,653
+39,718
| +88% | +$2.6M | 0.28% | 113 |
|
|
2024
Q3 | $3.5M | Buy |
+44,935
| New | +$3.5M | 0.19% | 166 |
|
|
2024
Q1 | – | Sell |
-18,058
| Closed | -$1.22M | – | 379 |
|
|
2023
Q4 | $1.22M | Buy |
+18,058
| New | +$1.22M | 0.08% | 229 |
|
|
2022
Q3 | – | Sell |
-66,238
| Closed | -$4.38M | – | 443 |
|
|
2022
Q2 | $4.38M | Sell |
66,238
-31,472
| -32% | -$2.08M | 0.18% | 167 |
|
|
2022
Q1 | $6.48M | Buy |
97,710
+32,910
| +51% | +$2.18M | 0.24% | 122 |
|
|
2021
Q4 | $3.78M | Buy |
64,800
+34,800
| +116% | +$2.03M | 0.17% | 195 |
|
|
2021
Q3 | $1.8M | Buy |
+30,000
| New | +$1.8M | 0.09% | 298 |
|